Addiction management is key to treating heart infection in people who inject drugs miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
WEDNESDAY, Aug. 31, 2022 (HealthDay News) For infective endocarditis cases among people who inject drugs, management is complex and requires a unique approach involving multiple specialists, including addiction-trained clinicians, according to a scientific statement issued by the American Heart Association and published online Aug. 31 in Circulation. Larry M. Baddour, M.D., from the Mayo
American Heart Association
Statement Highlights:
Good oral hygiene and regular dental care are the most important ways to reduce risk of a heart infection called infective endocarditis caused by bacteria in the mouth.
There are four categories of heart patients considered to be at highest risk for adverse outcomes from infective endocarditis, and only these patients are recommended to receive preventive antibiotic treatment prior to invasive dental procedures.
American Heart Association guidelines issued in 2007 suggested not to use antibiotics before certain dental procedures. These recommendations resulted in a decrease in antibiotic use.
DALLAS, April 15, 2021 – Maintenance of good oral health is more important than use of antibiotics in dental procedures for some heart patients to prevent a heart infection caused by bacteria around the teeth, according to a new American Heart Association (AHA) scientific statement published today in the association’s flagship journal,
February 01, 2021
New data on infective endocarditis (IE) among people who inject drugs run counter to long-held stereotypes about the condition for example, a sizeable proportion of cases affect the heart’s left side, occur in prosthetic valves, and arise from organisms other than
Staphylococcus aureus.
Journal of the American College of Cardiology.
According to the study authors, the series represents the largest of its kind to date in this patient group and should drive home the point that while there are well-known features of “classical” IE in injection-drug users, understanding some of the “not so typical” findings will be key to patient management.